Navigation Links
Conflict of Interest Disclosures Tool Updated
Date:5/11/2011

JERICHO, N.Y., May 11, 2011 /PRNewswire/ -- HCCS (Health Care Compliance Strategies, Inc.), the leading provider of online healthcare compliance and competency training and tracking solutions, today announced the release of an enhanced version of COI-SMART, a web-based system for the management and real-time tracking of Conflict of Interest disclosures. HCCS built this comprehensive tool in response to tighter government regulations and increased scrutiny.

(Logo:  http://photos.prnewswire.com/prnh/20061010/NYTU194LOGO)

"COI-SMART has a tremendous impact on the conflicts of interest disclosure management process for our clients," says Ben Diamond, President of HCCS. "It was important for us to take the system to the next level with this series of enhancements. We're already receiving great positive feedback. These enhancements make the system an invaluable tool for our clients."

COI-SMART facilitates the review process through automation, providing healthcare organizations with improved control, reduced risk and increased transparency at a lower total cost than their current COI disclosure and review process. COI-SMART provides organizations with the tools for automated assignment of reviewers, the development of conflict of interest management plans, and data mining tools for auditing, tracking and reporting on potential conflicts of interest.

Enhancements to the COI-SMART system include a streamlined process for creating and assigning questionnaires, improved reviewer assignments process, enhanced user interface and increased application performance and responsiveness.

The COI-SMART system expands HCCS' product line of online multimedia courseware and Learning Management Systems designed for healthcare organizations.  

About HCCS

Health Care Compliance Strategies, Inc (HCCS) provides up-to-date compliance and competency training and tracking solutions to hospitals, health plans, teaching facilities, medical schools and other healthcare entities.  HCCS programs are used at hundreds of healthcare facilities nationwide, with over one million registered learners.  HCCS provides a full library of online compliance and competency training courses to fulfill the demanding needs of healthcare staff training, including Professional Compliance, Corporate Compliance, HIPAA Compliance, Research Compliance, Patient Safety and Competency for Quality Care, among many others.  The HCCS Healthcare Learning Platform (HLP) is a healthcare specific Learning and Talent Management System.  The HCCS COI-SMART system provides a comprehensive tool for tracking and managing Conflict of Interest disclosures.

For more information about HCCS products, contact HCCS at (877) 933-4227, by email at info@hccs.com, or via the web at www.hccs.com.


'/>"/>
SOURCE Health Care Compliance Strategies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Conflict of Interest Management System Selected by Henry Ford Health System
2. CMU Receives $1.2 Million NIH Grant To Develop Ethics, Policy Recommendations for Post-Conflict, Post-Disaster DNA ID Practices
3. Managing Conflict of Interest Disclosures Simplified for Healthcare Organizations
4. Perceptive Informatics Global Survey Results Show Growing Industry Interest in Implementing Adaptive Trial Designs
5. Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety
6. TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch
7. ‘Next Big Idea' Fest Aims to Spark Interest Among NM Youth in Science, Technology as Future Career Path
8. Interest in Environment & Sustainability Prevails in Food Technology Survey
9. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
10. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
11. New and Interesting PROSTVAC(TM) Data Indicate Broad Therapeutic Use in Metastatic Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):